Target intelligence / Profile preview

Human Leukocyte Antigen – DR (HLA-DR)

Target
HLA-DR
Molecular classification
MHC Class II Cell Surface Receptor, Receptor
01

Overview

HLA-DR is a cell surface receptor belonging to the major histocompatibility complex (MHC) class II family. It is primarily involved in presenting peptide antigens to the immune system, specifically to T-helper cells. While typically found on professional antigen-presenting cells, HLA-DR can also be expressed by non-immune epithelial cells under certain conditions, particularly in response to inflammatory stimuli on the ocular surface. Its expression level serves as a biomarker for ocular surface inflammation and disease severity, especially in dry eye disease.

Other names
MHC Class IIMajor Histocompatibility Complex Class IIHLA class II histocompatibility antigen, DR alpha chainHLA class II histocompatibility antigen, DR beta chain
02

Biological functions

Antigen presentationT-cell activationImmune responseAdaptive immunity
03

Disease associations

Dry Eye DiseaseOcular Surface InflammationAutoimmune disordersInflammatory processes
04

Safety considerations

Varied sensitivity among individualsMay not be a sensitive marker for DED in all patients
05

Biomarkers

Ocular surface inflammationDry eye severityCorneal fluorescein stainingConjunctival damage

Beyond the preview

Go deeper on Human Leukocyte Antigen – DR (HLA-DR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human Leukocyte Antigen – DR (HLA-DR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call